Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Watowich, is advancing a lead NNMT inhibitor candidate ( RT-002 ) toward Phase 1 first-in-human clinical trials, with IND-enabling GLP toxicology studies in minipigs currently underway
Their side effect profile differs substantially from AOD 9604
Scientific Research (1) Neelakantan H, Vance V, Wetzel MD, Wang HL, McHardy SF, Finnerty CC, Hommel JD, Watowich SJ
Medical Weight Loss Programs Promotes fat mobilization from the liver and adipose tissue Supports metabolic efficiency and detoxification Reduces fatigue and energy crashes often associated with dieting 2
What most pages get wrong about buying AOD-9604 How does AOD-9604 compare to real alternatives
US$ 29.54
US$ 26.14
US$ 28.03
US$ 29.20
US$ 22.66
US$ 27.16
US$ 23.43
US$ 26.39
US$ 29.87
US$ 23.77
US$ 20.10
